**Core Concept:** In patients with diabetes mellitus and proteinuria, the choice of antihypertensive drug is crucial to prevent further renal damage and maintain renal function. Proteinuria is a marker of glomerular damage, and antihypertensive therapy aims to reduce blood pressure, prevent proteinuria, and reduce the risk of end-stage renal disease.

**Why the Correct Answer is Right:** ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) are the first-line choice for antihypertensive therapy in diabetic patients with proteinuria. They work by blocking the conversion of angiotensin I to angiotensin II, thereby reducing the formation of aldosterone and preventing sodium retention, which is essential in reducing proteinuria. ACE inhibitors have been shown to slow the progression of diabetic nephropathy and reduce the risk of end-stage renal disease.

**Why Each Wrong Option is Incorrect:**

A. Angiotensin II receptor blockers (ARBs): ARBs also block the renin-angiotensin-aldosterone system, but they do not inhibit the formation of angiotensin II directly. Therefore, they may not have the same level of effect on reducing proteinuria as ACE inhibitors.

B. Calcium channel blockers (CCBs): CCBs primarily act by blocking calcium entry into vascular smooth muscle cells, leading to vasodilation and reduced peripheral vascular resistance. They do not directly target the renin-angiotensin-aldosterone system, which is crucial in reducing proteinuria in diabetic nephropathy.

C. Diuretics: Diuretics (loop and thiazide diuretics) reduce blood pressure and fluid overload but do not directly target the renin-angiotensin-aldosterone system. This results in a less potent effect on reducing proteinuria compared to ACE inhibitors and ARBs.

D. Beta-blockers: Beta-blockers primarily act by blocking the action of catecholamines on beta receptors, which is not directly related to the renin-angiotensin-aldosterone system or reducing proteinuria in diabetic nephropathy.

**Clinical Pearl:** In patients with diabetic nephropathy, the choice of antihypertensive medication should focus on drugs that directly target the renin-angiotensin-aldosterone system, such as ACE inhibitors and ARBs, to achieve the desired effects of reducing proteinuria and slowing the progression of diabetic nephropathy.

**Correct Answer:** ACE inhibitors (e.g., Enalapril or Ramipril) or Angiotensin II receptor blockers (e.g., Losartan or Irbesartan) are the preferred choice in patients with diabetic nephropathy due to their direct effect on the renin-angiotensin-aldosterone system and their beneficial effects on reducing proteinuria and slowing the progression of diabetic nephropathy.